Terms: = Ovarian cancer AND NDRG1, NDR1, 10397, ENSG00000104419, Q92597, RIT42, CMT4D, TARG1, HMSNL, GC4, RTP, TDD5, PROXY1, NMSL, CAP43
15 results:
1. N-Myc Downstream Regulated Gene-1 May Play an Important Role in the Prognosis of ovarian cancer, in Its Association with Beta-Catenin.
Terada A; Tsuda N; Tasaki S; Park J; Nasu H; Tasaki K; Katsuda T; Nishio S; Yamaguchi T; Sanada S; Akiba J; Kuwano M; Ono M; Ushijima K
Kurume Med J; 2023 Nov; 69(1.2):39-46. PubMed ID: 37793886
[TBL] [Abstract] [Full Text] [Related]
2. A review on the role of ndrg1 in different cancers.
Ghafouri-Fard S; Ahmadi Teshnizi S; Hussen BM; Taheri M; Sharifi G
Mol Biol Rep; 2023 Jul; 50(7):6251-6264. PubMed ID: 37249826
[TBL] [Abstract] [Full Text] [Related]
3. Circulating cell-free endometrial DNA level is unaltered during menstruation and in endometriosis.
Yuwono NL; Alonso A; Abbott J; Houshdaran S; Henry CE; Rodgers R; Ford CE; Warton K
Hum Reprod; 2022 Oct; 37(11):2560-2569. PubMed ID: 36166696
[TBL] [Abstract] [Full Text] [Related]
4. Protein expression profiling identifies a prognostic model for ovarian cancer.
Xiong L; Tan J; Feng Y; Wang D; Liu X; Feng Y; Li S
BMC Womens Health; 2022 Jul; 22(1):292. PubMed ID: 35840928
[TBL] [Abstract] [Full Text] [Related]
5. Up-regulation of hypoxia-inducible factor antisense as a novel approach to treat ovarian cancer.
Lu T; Tang J; Shrestha B; Heath BR; Hong L; Lei YL; Ljungman M; Neamati N
Theranostics; 2020; 10(15):6959-6976. PubMed ID: 32550915
[TBL] [Abstract] [Full Text] [Related]
6. The novel dithiocarbamate, DpdtC suppresses HER2-overexpressed cancer cells by up-regulating ndrg1 via inactivation of HER2-ERK 1/2 signaling.
Yang Y; Liu Y; Guo R; Fu Y; Zhang Z; Zhang P; Zhou P; Wang T; Huang T; Li X; Li C
Sci Rep; 2018 Feb; 8(1):3398. PubMed ID: 29467385
[TBL] [Abstract] [Full Text] [Related]
7. Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis.
Klymenko Y; Kim O; Loughran E; Yang J; Lombard R; Alber M; Stack MS
Oncogene; 2017 Oct; 36(42):5840-5851. PubMed ID: 28628116
[TBL] [Abstract] [Full Text] [Related]
8. Identification of ovarian cancer subtype-specific network modules and candidate drivers through an integrative genomics approach.
Zhang D; Chen P; Zheng CH; Xia J
Oncotarget; 2016 Jan; 7(4):4298-309. PubMed ID: 26735889
[TBL] [Abstract] [Full Text] [Related]
9. N-myc downstream regulated gene 1 acts as a tumor suppressor in ovarian cancer.
Wang B; Li J; Ye Z; Li Z; Wu X
Oncol Rep; 2014 May; 31(5):2279-85. PubMed ID: 24626771
[TBL] [Abstract] [Full Text] [Related]
10. Chronic stress promoted the growth of ovarian carcinoma via increasing serum levels of norepinephrine and interleukin-10 and altering nm23 and ndrg1 expression in tumor tissues in nude mice.
Gao G; Sun J; Gao J; Xiong L; Yu L; Gao Y
Biosci Trends; 2013 Feb; 7(1):56-63. PubMed ID: 23524894
[TBL] [Abstract] [Full Text] [Related]
11. N-myc downstream-regulated gene 1/cap43 may function as tumor suppressor in endometrial cancer.
Lv XH; Chen JW; Zhao G; Feng ZZ; Yang DH; Sun WW; Fan JS; Zhu GH
J Cancer Res Clin Oncol; 2012 Oct; 138(10):1703-15. PubMed ID: 22678098
[TBL] [Abstract] [Full Text] [Related]
12. Identification of ndrg1-regulated genes associated with invasive potential in cervical and ovarian cancer cells.
Zhao G; Chen J; Deng Y; Gao F; Zhu J; Feng Z; Lv X; Zhao Z
Biochem Biophys Res Commun; 2011 Apr; 408(1):154-9. PubMed ID: 21463610
[TBL] [Abstract] [Full Text] [Related]
13. N-myc downstream-regulated gene 1 as a downregulated target gene of PTEN in the controlling of tumourigenesis in endometrioid carcinoma.
Li S; Chen J; Yang Z; Lu G; Tang H; Hu H
Indian J Med Res; 2008 May; 127(5):453-9. PubMed ID: 18653908
[TBL] [Abstract] [Full Text] [Related]
14. Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway.
Unoki M; Nakamura Y
Oncogene; 2001 Jul; 20(33):4457-65. PubMed ID: 11494141
[TBL] [Abstract] [Full Text] [Related]
15. [Epidemiology of childhood tumors in the Piedmont and Valle d'Aosta regions during the 1965-69 period].
Pastore G; Terracini B
Tumori; 1975; 61(3):291-304. PubMed ID: 1162753
[TBL] [Abstract] [Full Text] [Related]
